Diabetes decisions — 2024

The Board has dismissed the appeals for various ratings and effective dates due to the appellant's death.

The Veteran's claim for service connection for erectile dysfunction secondary to type two diabetes mellitus is granted with an effective date of October 1, 2020.

Effective June 29, 2021, the Veteran's diabetes mellitus, type II and hypothyroidism have been granted as secondary to Agent Orange exposure.,Effective June 29, 2021, the Veteran's diabetic neuropathy of various extremities and diabetic nephropathy are also granted as secondary to his diabetes mellitus, type II.

The Board has remanded the claims for service connection for diabetes mellitus, type II and hypertension as secondary to bilateral pes planus due to insufficient VA medical opinions addressing the Veteran's contentions.

The Veteran's claim for reimbursement of Beneficiary Travel mileage expenses to a Kansas City VAMC on December 11, 2023, is granted due to the travel being related to his service-connected disabilities and he was timely in filing his claim.

The Veteran's diabetes mellitus type II is presumed to be related to exposure to herbicide agents during his service aboard the USS Charles R. Ware, which was within 12 nautical miles of the Republic of Vietnam.

The Veteran's service connection claims for various conditions, including diabetes mellitus type 2, bilateral leg condition, bilateral foot conditions, and visual impairment (claimed as vision loss), were denied. The Board found no evidence to support a nexus between these conditions and the Veteran's military service.

The Veteran's appeal for a higher rating of his service-connected Diabetes Mellitus Type I with erectile dysfunction is dismissed because the Veteran did not identify a specific decision he disagrees with in his Notice of Disagreement.

The Veteran's service-connected disabilities do not result in the physical loss or permanent loss of use of one or both hands or feet, nor does it meet any other criteria for financial assistance in the purchase of an automobile or adaptive equipment. The Board denied the claim as there is no evidence of permanent loss of use of a hand or foot due to service-connected disability.

The Veteran's claims for service connection for diabetes mellitus, peripheral neuropathy of the upper and lower extremities are being remanded due to new evidence received since the last decision.,New evidence has been submitted regarding potential in-service chemical exposure leading to current conditions. The claim is being readjudicated.

The Board has granted service connection for diabetes mellitus type II (DMII) secondary to the Veteran's service-connected post-traumatic stress disorder (PTSD). The decision is based on a private medical opinion that concluded the PTSD caused obesity, which in turn led to DMII.

The Board has granted service connection for diabetes mellitus, type II as secondary to the Veteran's service-connected degenerative arthritis of the spine with intervertebral disc syndrome.

The Veteran's hypertension and diabetes mellitus type II are being remanded for further evaluation due to the need for a VA opinion considering obesity as an intermediate step between his service-connected disabilities and these conditions.

The Board has remanded the claims of service connection for diabetes mellitus and gastroesophageal reflux disease due to duty-to-assist errors. The Veteran's claim will be reconsidered with additional development.

The Board has remanded the claims for service connection for diabetes mellitus, sleep apnea, right knee disability, and left knee disability due to an error in providing notice of the Veteran's right to a hearing.

The Veteran's diabetic peripheral neuropathy of the right and left lower extremities is granted a 40 percent rating each, effective September 1, 2020.

The appeals for service connection of diabetes mellitus, Parkinson's Disease, and bilateral neuropathy have been dismissed due to the Veteran's death.

The Veteran's claims for service connection for coronary artery disease and diabetes mellitus, type II are granted due to presumed exposure to herbicide agents during his military service.

The Board has decided to remand the substitution request and the entitlement to accrued benefits due to a regulatory error in not adjudicating the substitution request at the time of the Veteran's death. The relevant service treatment records, which showed the Veteran was diagnosed with diabetes during active duty, were associated after the June 2012 legacy decision.

The appeal is dismissed as the Veteran has not appealed a Rapid Appeals Modernization Program (RAMP) rating decision or a notification letter dated on or after February 19, 2019.